What's Happening?
Novartis has been nominated for a UX Design Award for its innovative digital onboarding experience developed in collaboration with Team Consulting. This platform is designed to assist patients with relapsing forms of multiple sclerosis (RMS) in learning
to self-inject their medication safely and confidently at home. The digital platform, accessible via a QR code on the product packaging, offers a range of learning materials, including written guidance, animated instructional videos, and an interactive virtual practice environment. This initiative aims to address challenges such as inconsistent onboarding and injection anxiety, which can lead to reduced confidence and use errors. The UX Design Awards, organized by the International Design Center Berlin, recognize solutions that improve lives through effective design.
Why It's Important?
The nomination of Novartis for the UX Design Award highlights the growing importance of user-centered design in healthcare. By providing a digital onboarding experience, Novartis aims to enhance patient confidence and reduce the need for repeated in-person training, thereby easing the burden on healthcare systems. This approach not only improves patient experience but also supports better health outcomes by ensuring that patients can manage their treatment effectively at home. The recognition of this platform underscores the value of integrating human factors expertise and behavioral science in digital design, which can lead to safer and more effective use of medical devices.
What's Next?
The winners of the UX Design Award will be announced in September. If Novartis wins, it could further validate the importance of digital solutions in healthcare and encourage other companies to invest in similar patient-centered technologies. This could lead to broader adoption of digital platforms in medical training and patient support, potentially transforming how patients interact with healthcare products and services.
